151 related articles for article (PubMed ID: 3373745)
1. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
Sakai M
Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
[No Abstract] [Full Text] [Related]
2. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
Fukuchi S
Nihon Rinsho; 1988 Jan; 46(1):119-23. PubMed ID: 3373744
[No Abstract] [Full Text] [Related]
3. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
Sakai H; Oka H; Sakaguchi M
Nihon Rinsho; 1988 Jan; 46(1):114-8. PubMed ID: 2897481
[No Abstract] [Full Text] [Related]
4. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; synergistic drugs for protective factors in peptic ulcer].
Miyake T
Nihon Rinsho; 1988 Jan; 46(1):79-83. PubMed ID: 3373760
[No Abstract] [Full Text] [Related]
5. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; mucosal blood-flow improving agents].
Shimakura S; Fukutomi H
Nihon Rinsho; 1988 Jan; 46(1):55-63. PubMed ID: 3373758
[No Abstract] [Full Text] [Related]
6. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
Ishikawa M; Saito H; Sato J
Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486
[No Abstract] [Full Text] [Related]
7. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
Takemoto T; Yanai H
Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
[No Abstract] [Full Text] [Related]
8. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
[No Abstract] [Full Text] [Related]
9. Role of protective drugs in the prevention of ulcer relapse.
Ota S; Terano A
J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of stress ulcer with topically acting drugs: an effective and sensible therapeutic approach? Arguments contra].
Janisch HD
Z Gastroenterol; 1991 Jan; 29 Suppl 1():19-20; discussion 21-2. PubMed ID: 1962496
[No Abstract] [Full Text] [Related]
11. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
[TBL] [Abstract][Full Text] [Related]
12. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; tissue healing inducing drugs].
Mori H; Sato H; Seki Y
Nihon Rinsho; 1988 Jan; 46(1):50-4. PubMed ID: 3373757
[No Abstract] [Full Text] [Related]
13. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
15. Review of peptic ulcer maintenance trials.
Robinson M
Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
[TBL] [Abstract][Full Text] [Related]
16. [Antirecurrence treatment of peptic ulcer].
Papikian MKh; Vaĭstukh SI; Kulabukhov VG
Ter Arkh; 1980; 52(7):118-21. PubMed ID: 6996196
[No Abstract] [Full Text] [Related]
17. [Interactions of cimetidine and ranitidine with other drugs].
Paradowski L; Szelag A
Pol Tyg Lek; 1988 Aug; 43(35):1120-2. PubMed ID: 2908001
[No Abstract] [Full Text] [Related]
18. [Current aspects of course treatment and secondary prevention of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
[No Abstract] [Full Text] [Related]
19. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of cimetidine and cetraxate in the treatment of peptic ulcer.
Archimandritis A; Tjivras M; Alexiou A; Bougas S; Fertakis A
J Clin Gastroenterol; 1991 Feb; 13(1):114-5. PubMed ID: 2007733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
